CD28 and breast carcinoma: Teutsch et al. (2004) described the CD28 (rs35593994) SNP through identification of transcription factor binding sites, showing that the A allele possesses a CCAAT enhancer-binding protein site, which is lacking in allele G. Additional reports showed that this variant influences gene transcription and immune alteration in breast cancer [58,59].